H.J. Res. 168 (119th)Bill Overview

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule…

domestic policy
Cosponsors
Support
Democratic
Introduced
Apr 30, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Financial Services.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This joint resolution uses the Congressional Review Act (chapter 8, title 5, U.S. Code) to disapprove a rule submitted by the Bureau of Consumer Financial Protection (CFPB) that withdrew Bulletin 2022–01.

If enacted, the resolution would render the CFPB’s withdrawal rule (90 Fed.

Reg. 20084 (May 12, 2025)) void and leave Bulletin 2022–01 (87 Fed.

Passage30/100

Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that is concise and specific about its immediate legal effect but sparse on fiscal, transitional, and downstream-detailing elements.

Contention75/100

Consumer protection vs. regulatory burden on providers

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
ConsumersFederal agencies
Likely helped
  • ConsumersRestores CFPB guidance limiting medical debt collection and consumer reporting practices.
  • ConsumersReduces the likelihood that certain medical debts will appear on consumer credit reports.
  • Targeted stakeholdersMay decrease collection activity for disputed surprise billing amounts affecting vulnerable patients.
Likely burdened
  • Targeted stakeholdersIncreases compliance costs for hospitals, providers, and third‑party debt collectors.
  • Targeted stakeholdersMay reduce the quantity of medical debt information available for credit underwriting decisions.
  • Federal agenciesCreates regulatory uncertainty and could prompt litigation over agency authority and the bulletin.
03 · Why people split

Why the argument around this bill splits.

Consumer protection vs. regulatory burden on providers
Progressive95%

Likely strongly supportive because the resolution preserves CFPB guidance limiting medical-debt reporting and protecting consumers under the No Surprises Act.

Supporters will view nullifying the withdrawal as defending consumer credit scores and enforcement clarity.

They may emphasize the bulletin’s role in preventing unfair billing and collection practices.

Leans supportive
Centrist65%

Cautiously supportive but pragmatic.

Centrist observers appreciate consumer protections and clarity, yet worry about using the CRA to micromanage agency rulemaking and potential costs to health providers.

They will seek clearer cost-benefit information and narrowly tailored language.

Split reaction
Conservative15%

Likely opposed.

Conservatives will view the resolution as preserving an overbroad CFPB guidance that expands federal oversight of medical billing and imposes burdens on providers.

They prefer allowing the CFPB to withdraw the bulletin and favor less federal intervention in private billing practices.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Executive branch position on the underlying rule
  • Senate filibuster and 60-vote threshold dynamics
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Consumer protection vs. regulatory burden on providers

Narrow administrative target improves clarity, but partisan stakes and Senate procedural barriers make enactment uncertain.

Unlocked analysis

Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that is concise and specific about its immediate legal effect but sparse on fiscal, transitional, and downs…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis